Zynerba Release: Company Announces Proposed Public Offering Of Common Stock Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017 <b>Inova Translational Medicine Institute</b> Partners With <b>Cloudera</b> To Advance Genome-Based Machine Learning Initiatives And Save Lives June 6, 2017 European Regulatory Committee Recommends Rejecting Puma Biotechnology’s Breast Cancer Medicine February 22, 2018
On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017
<b>Inova Translational Medicine Institute</b> Partners With <b>Cloudera</b> To Advance Genome-Based Machine Learning Initiatives And Save Lives June 6, 2017
European Regulatory Committee Recommends Rejecting Puma Biotechnology’s Breast Cancer Medicine February 22, 2018